Great. Good morning, everyone. Thanks for joining us here at day 2 of the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at Leerink.

MGS has introduced the Auto-injector Reimagined (A.i.r.) drug-delivery device platform, drawing on its own history of creating unique designs and manufacturing millions of auto-injector sub-assemblies ...

Argenx delivered Q4 2025 product net sales of $1.3B and $4.2B for the full year, up 90% year over year as VYVGART demand accelerated globally. The company reported Q4 operating profit of $367M and ...

Moby summary of Stevanato Group S.p.A.'s Q4 2025 earnings call ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...